🇺🇸 Bevespi in United States

FDA authorised Bevespi on 25 April 2016

Marketing authorisations

FDA — authorised 25 April 2016

  • Application: NDA208294
  • Marketing authorisation holder: ASTRAZENECA
  • Status: supplemented

FDA

  • Status: approved

Bevespi in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Bevespi approved in United States?

Yes. FDA authorised it on 25 April 2016; FDA has authorised it.

Who is the marketing authorisation holder for Bevespi in United States?

ASTRAZENECA holds the US marketing authorisation.